Host Cell Protein Testing Market: Innovations & Competitive Analysis - Forecast To 2028
Market Highlights
The global host cell protein testing market is
expected to register a CAGR of 5.80% during the forecast period and is expected
to hit USD 1,621.18 million by 2027.
The growth of the global host cell protein testing market is
expected to be driven by the developments in the biopharmaceutical field, and
growing R&D activities. Also, introduction of automated mass spectrometry
for host cell protein detection is creating opportunities for the host cell
protein testing market.
The growth of the global Host
Cell Protein Testing Market is expected to be driven by key factors
such as developments in the biopharmaceutical field, and growing R&D
activities. However, factors such as concerns pertaining to immunogenicity, and
issues related to the efficiency and accuracy of the test kits are expected to
restrict the market growth. In contrast, introduction of automated mass
spectrometry for single
cell protein detection offers lucrative opportunities for the global
host cell protein testing market players.
Some of the key players operating in the host cell
protein testing market are Enzo Life Sciences, Inc. (US), Cytiva (US), Thermo
Fisher Scientific Inc.(US) , Bio-Rad Laboratories, Inc. (US), Cygnus
Technologies, Llc (US) , Biogenes Gmbh (Germany), Cisbio Bioassays (Europe),
Charles River Laboratories International, Inc. (US), Rockland Immunochemicals,
Inc.(US) and Abcam Plc (UK).
Segment Analysis
The global host cell protein testing market is mainly
segmented into type and end user.
On the basis of type, the host cell protein testing
market has been sub-segmented into PCR-based assays, ELISA-based assays, and
mass spectrometry-based assays.
On the basis of end user, the host cell protein
testing market has been segmented into contract research organizations, and
biopharmaceutical companies.
Regional Analysis
The global host cell protein testing market has been
segmented on the basis of region into North America, Europe, Asia-Pacific, and
the Rest of the World. The North American market is further divided into the US
and Canada. The European host cell protein testing market has been segmented
into Germany, France, the UK, Italy, Spain, and the rest of Europe. The host
cell protein testing market in Asia-Pacific has been segmented into China,
India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of
the World host cell protein testing market includes the Middle East, Africa,
and Latin America.
North America accounted for a market size of USD 406.24
million in 2020 and is expected to exhibit a CAGR of 5.18% during the forecast
period. It dominated the global host cell protein testing market due to various
factors, such as developments in the biopharmaceutical industries, increasing
investment in R&D activities, and well-established healthcare
infrastructure in the region. The US has minimal barriers and the most
supportive domestic environment for the development and commercialization of
pharmaceuticals. This attracts capital investments in biopharmaceutical
enterprises startups. Moreover, the collaboration and partnerships of the
market players are expected to bring about highly innovative, industry-leading
products driving the demand for host cell protein testing across the region.
Canada also has a high number of biotechnology companies. According to the
Canadian Life Sciences Database, currently, the number of biotech companies in
Canada is 1,042. This is fueling the growth of the host cell protein testing
market in the region.
Europe has also evolved as a prominent market for host cell
protein testing, with well-established R&D facilities across the region,
the presence of supportive regulatory systems, development of innovative and
cost-effective host cell protein testing solutions by the companies. According
to Statista, in 2020, USD 1,232.07 million (1,045 million euros) were spent on
R&D by listed biotechnology companies. The UK has a unique worldwide health
and life sciences ecosystem and a strong track record of scientific
breakthroughs with next-generation technologies and services. The government
provides an R&D platform for the companies in the market. Government
initiatives and research funding are also fueling the growth of this market.
Key Findings of the Study
·
The global host cell protein testing market is
expected to reach USD 1,621.18 million by 2027 at a CAGR of 5.80% during the
forecast period.
·
The North America region accounted for the
largest share of 34% in the global market in 2020, which is majorly attributed
to the developments in the biopharmaceutical field, and growing R&D
activities.
·
Based on type, the mass spectrometry-based
assays segment is expected to register a CAGR of 32% during the forecast
period.
·
Based on end user, the biopharmaceutical
companies dominated the market with a share of 48.21% in 2020.
Market Research Future (MRFR)
enable customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of
Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New
York,
New York 10013
Comments
Post a Comment